BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15009434)

  • 1. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.
    Williams A; Reljic R; Naylor I; Clark SO; Falero-Diaz G; Singh M; Challacombe S; Marsh PD; Ivanyi J
    Immunology; 2004 Mar; 111(3):328-33. PubMed ID: 15009434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection.
    Reljic R; Clark SO; Williams A; Falero-Diaz G; Singh M; Challacombe S; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2006 Mar; 143(3):467-73. PubMed ID: 16487246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery.
    Falero-Diaz G; Challacombe S; Rahman D; Mistry M; Douce G; Dougan G; Acosta A; Ivanyi J
    Int Arch Allergy Immunol; 2000 Jun; 122(2):143-50. PubMed ID: 10878493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice.
    Buccheri S; Reljic R; Caccamo N; Ivanyi J; Singh M; Salerno A; Dieli F
    Eur J Immunol; 2007 Mar; 37(3):729-37. PubMed ID: 17304630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.
    López Y; Yero D; Falero-Diaz G; Olivares N; Sarmiento ME; Sifontes S; Solis RL; Barrios JA; Aguilar D; Hernández-Pando R; Acosta A
    Int J Med Microbiol; 2009 Aug; 299(6):447-52. PubMed ID: 19157977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel human IgA monoclonal antibody protects against tuberculosis.
    Balu S; Reljic R; Lewis MJ; Pleass RJ; McIntosh R; van Kooten C; van Egmond M; Challacombe S; Woof JM; Ivanyi J
    J Immunol; 2011 Mar; 186(5):3113-9. PubMed ID: 21257971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis.
    Iankov ID; Petrov DP; Mladenov IV; Haralambieva IH; Kalev OK; Balabanova MS; Mitov IG
    Microbes Infect; 2004 Aug; 6(10):901-10. PubMed ID: 15310466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract.
    Mazanec MB; Lamm ME; Lyn D; Portner A; Nedrud JG
    Virus Res; 1992 Apr; 23(1-2):1-12. PubMed ID: 1318622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?
    Reljic R; Williams A; Ivanyi J
    Tuberculosis (Edinb); 2006; 86(3-4):179-90. PubMed ID: 16510311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.
    Phalipon A; Kaufmann M; Michetti P; Cavaillon JM; Huerre M; Sansonetti P; Kraehenbuhl JP
    J Exp Med; 1995 Sep; 182(3):769-78. PubMed ID: 7544397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection.
    Alvarez N; Otero O; Camacho F; Borrero R; Tirado Y; Puig A; Aguilar A; Rivas C; Cervantes A; Falero-Díaz G; Cádiz A; Sarmiento ME; Norazmi MN; Hernández-Pando R; Acosta A
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S3. PubMed ID: 23458564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Pal S; Bravo J; Peterson EM; de la Maza LM
    Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ.
    Tran AC; Diogo GR; Paul MJ; Copland A; Hart P; Mehta N; Irvine EB; Mussá T; Drake PMW; Ivanyi J; Alter G; Reljic R
    Front Immunol; 2020; 11():582833. PubMed ID: 33193394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
    Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
    Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38kDa antigen in pulmonary tuberculosis.
    Uma Devi KR; Ramalingam B; Brennan PJ; Narayanan PR; Raja A
    Tuberculosis (Edinb); 2001; 81(3):249-53. PubMed ID: 11466037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal IgA class-switch variants against bacterial surface antigens: molecular forms and transport into murine respiratory secretions.
    Steinmetz I; Albrecht F; Häussler S; Brenneke B
    Eur J Immunol; 1994 Nov; 24(11):2855-62. PubMed ID: 7957576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA response to ESAT-6/CFP-10 and Rv2031 antigens varies in patients with culture-confirmed pulmonary tuberculosis, healthy Mycobacterium tuberculosis-infected and non-infected individuals in a tuberculosis endemic setting, Ethiopia.
    Legesse M; Ameni G; Medhin G; Mamo G; Franken KL; Ottenhoff TH; Bjune G; Abebe F
    Scand J Immunol; 2013 Sep; 78(3):266-74. PubMed ID: 23713613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice.
    Reljic R; Di Sano C; Crawford C; Dieli F; Challacombe S; Ivanyi J
    Tuberculosis (Edinb); 2005; 85(1-2):81-8. PubMed ID: 15687031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.